Douglas Holtzman

Douglas Holtzman

Directeur Technique/Scientifique/R&D chez ICOSAVAX, INC.
62 ans
Consumer Services
Health Technology
Commercial Services

Profil

Douglas Holtzman is the founder of Palindrome Bioconsulting LLC, which was founded in 2016.
He is currently the Chief Scientific Officer at Icosavax, Inc. since 2019.
Previously, he worked as the Deputy Director-Childhood Pneumonia at Bill & Melinda Gates Foundation from 2004 to 2012, and as the Vice President-Discovery at Takeda Pharmaceuticals U.S.A., Inc. from 2012 to 2016.
Holtzman received his undergraduate degree from Tufts University, his doctorate from the University of California, Berkeley, and his graduate degree from Harvard T.H.
Chan School of Public Health.

Postes actifs de Douglas Holtzman

SociétésPosteDébut
ICOSAVAX, INC. Directeur Technique/Scientifique/R&D 01/08/2019

Anciens postes connus de Douglas Holtzman

SociétésPosteFin
Palindrome Bioconsulting LLC
Fondateur 01/08/2019
Corporate Officer/Principal 01/07/2016
Corporate Officer/Principal 01/01/2012
Voir l'expérience en détail de Douglas Holtzman

Formation de Douglas Holtzman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

48

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Commercial Services

Palindrome Bioconsulting LLC

  1. Bourse
  2. Insiders
  3. Douglas Holtzman